Results 161 to 170 of about 1,044,115 (187)
Some of the next articles are maybe not open access.
Synthetic lethality with cisplatin
Science Signaling, 2018Blocking the kinase MAST1 with lestaurtinib prevents cisplatin resistance in cancers driven by Raf-MEK signaling.
openaire +1 more source
A lethal combination for cancer cells: Synthetic lethality screenings for drug discovery
European Journal of Cancer, 2010In recent years, cancer drug discovery has faced the challenging task of integrating the huge amount of information coming from the genomic studies with the need of developing highly selective target-based strategies within the context of tumour cells that experience massive genome instability.
E. FERRARI, C. LUCCA, M. FOIANI
openaire +2 more sources
MYC, Metabolic Synthetic Lethality, and Cancer
2016The MYC oncogene plays a pivotal role in the development and progression of human cancers. It encodes a transcription factor that has broad reaching effects on many cellular functions, most importantly in driving cell growth through regulation of genes involved in ribosome biogenesis, metabolism, and cell cycle.
Annie L, Hsieh, Chi V, Dang
openaire +2 more sources
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Cell, 2021Kenneth Aldape +2 more
exaly
Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines
Cell Systems, 2021David Adams +2 more
exaly
Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age
Trends in Pharmacological Sciences, 2021Dexter Kai Hao Thng +2 more
exaly
CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
Cancers, 2021Jordi Surrallés, Laia Castells-Roca
exaly
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
Molecular Cell, 2021Deborah Schneider-Luftman +2 more
exaly